HopeAI
Princeton
About HopeAI
At HopeAI, we are on a mission to bring hope to patients by accelerating the clinical development of new treatments through AI. Patients cannot wait. We believe AI-enabled clinical trials are the key to bringing life-saving medicines to patients faster and more efficiently. Our initial approach involves crafting an AI copilot with up-to-date clinical evidence and profound statistical insights. This AI copilot will work alongside the clinical development team to make swift and data-optimized decisions throughout trial design and execution, enhancing probability of success and expediting time to market. As AI continues to advance, we envision a future where all promising drug candidates can be rapidly tested in AI-enabled clinical trials and made accessible to patients in need. We are committed to paving the 'highway' for clinical trials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Pre-Seed (Aug 2024)
- Website: hopeai.co
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Life Science, SaaS
Social Profiles
Canonical: https://fsome.com/organization/hopeai-2586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.